An atypical antidepressant medication believed to exert its effects through antagonism of central presynaptic alpha2-adrenergic receptors of both noradrenergic and serotonergic neurons. It has been characterized as a noradrenergic and specific serotonergic antidepressant (NaSSA). Marketed under the brand name remeron.